Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
Lung Cancer
About this trial
This is an interventional treatment trial for Lung Cancer focused on measuring stage I non-small cell lung cancer, stage II non-small cell lung cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of malignant non-small cell lung cancer (NSCLC) Intraoperative needle biopsy confirmation allowed Resectable disease (stage I or II) All tissue to be treated by radiofrequency tumor ablation must be completely contained within boundaries of planned lung resection Medically fit to undergo lung resection PATIENT CHARACTERISTICS: Age: Over 18 Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Not pregnant or nursing PRIOR CONCURRENT THERAPY: Biologic therapy: No prior or concurrent biologic therapy Chemotherapy: No prior or concurrent chemotherapy Endocrine therapy: No prior or concurrent endocrine therapy Radiotherapy: No prior or concurrent radiotherapy Surgery: See Disease Characteristics Other: No other prior therapy for NSCLC
Sites / Locations
- Fox Chase Cancer Center